Post-pandemic Era-Global Long-acting Injectable Medications Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin | Analytical Research Cognizance

Post-pandemic Era-Global Long-acting Injectable Medications Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin

Published by ARCXZ001
Report ID 1664919
Published date Mar 09, 2021
Category Pharmaceuticals and Healthcare
Total Pages 112
Choose license type Buy Now
Request a Sample Enquiry Before Buying Check Discount

Summary

World trade was already slowing in 2019 before COVID 19 outbreak, weighed down by trade tensions and slowing economic growth, such as uncertainty generated from Brexit, the U.S.-China trade war, the Japan-South Korea trade war.

Trade is expected to fall by between 13% and 32% in 2020 as the COVID 19 pandemic disrupts normal economic activity and life around the world, according to the study of WTO.The decline in exports has been mainly due to the ongoing global slowdown, which got aggravated due to the current Covid-19 crisis. The latter resulted in large scale disruptions in supply chains and demand resulting in cancellation of orders.

XYZResearch’s analysis shows that as China started reopening its economy, world exports initially recovered across the board. But estimates of the expected recovery in 2021 are uncertain, with outcomes depending largely on the duration of the outbreak and the effectiveness of the policy responses.

This research report indicated that the global Long-acting Injectable Medications market was valued at USD XXX million in 2019, and it is expected to reach a value of USD XXX million by 2026, at a CAGR of XX % over the forecast period 2021-2026. In terms of the export, China occupied more than XX % export market share in 2019, India occupied XX %. XXX is the second largest region around the world, it occupied about XX % export market share in 2019. In terms of the Local Capacity, XXX is the largest region around the world, it occupied about XX % export market share in 2019.

Regional Segmentation (Value; Revenue, USD Million, 2015 - 2026) of Long-acting Injectable Medications Market by XYZResearch Include
China
EU
North America
Japan
India
Southeast Asia
South America
Middle East and Africa

Competitive Analysis; Who are the Major Players in Long-acting Injectable Medications Market?
Eli Lilly
Nanomi
Alkermes
Zogenix
DURECT
Johnson & Johnson
MedinCell
Mapi Pharma
Oakwood Labs
GSK
Pharmathen
Kashiv BioSciences
...

Major Type of Long-acting Injectable Medications Covered in XYZResearch report:
First-generation
Second-generation

Application Segments Covered in XYZResearch Market
Schizophrenia
Contraception
HIV
Other

For any other requirements, please feel free to contact us and we will provide you customized report.

Chapter One: Market Scope
1.1 Product Details and Introduction
1.1.1 First-generation -Product Introduction and Major Manufacturers
1.1.2 Second-generation -Product Introduction and Major Manufacturers
1.2 Market Snapshot
1.2.1 Major Companies Overview
1.2.2 Market Concentration
1.2.3 Six-Year Compound Annual Growth Rate (CAGR)

Chapter Two: Regional Market Analysis
2.1 China Long-acting Injectable Medications Status and Prospect (2015-2026)
2.1.1 China Long-acting Injectable Medications Market Size and Growth Rate (2015-2026)
2.1.2 China Long-acting Injectable Medications Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.2 EU Long-acting Injectable Medications Status and Prospect (2015-2026)
2.2.1 EU Long-acting Injectable Medications Market Size and Growth Rate (2015-2026)
2.2.2 EU Long-acting Injectable Medications Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.3 USA Long-acting Injectable Medications Status and Prospect (2015-2026)
2.3.1 USA Long-acting Injectable Medications Market Size and Growth Rate (2015-2026)
2.3.2 USA Long-acting Injectable Medications Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.4 Japan Long-acting Injectable Medications Status and Prospect (2015-2026)
2.4.1 Japan Long-acting Injectable Medications Market Size and Growth Rate (2015-2026)
2.4.2 Japan Long-acting Injectable Medications Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.5 India Long-acting Injectable Medications Status and Prospect (2015-2026)
2.5.1 India Long-acting Injectable Medications Market Size and Growth Rate (2015-2026)
2.5.2 India Long-acting Injectable Medications Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.6 Southeast Asia Long-acting Injectable Medications Status and Prospect (2015-2026)
2.6.1 Southeast Asia Long-acting Injectable Medications Market Size and Growth Rate (2015-2026)
2.6.2 Southeast Asia Long-acting Injectable Medications Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.7 South America Long-acting Injectable Medications Status and Prospect (2015-2026)
2.7.1 South America Long-acting Injectable Medications Market Size and Growth Rate (2015-2026)
2.7.2 South America Long-acting Injectable Medications Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.8 Long-acting Injectable Medications Status and Prospect (2015-2026)
2.8.1 Long-acting Injectable Medications Market Size and Growth Rate (2015-2026)
2.8.2 Long-acting Injectable Medications Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)

Chapter Three: Global Long-acting Injectable Medications Market Assessment by Segment
3.1 Global Long-acting Injectable Medications Capacity and Growth Rate
3.2 Global Long-acting Injectable Medications Sales by Type
3.3 Global Long-acting Injectable Medications Sales Revenue by Type
3.4 Global Long-acting Injectable Medications Consumption by Application

Chapter Four: Global Long-acting Injectable Medications Market Assessment by Regions
4.1 Global Long-acting Injectable Medications Production Analysis and Forecast by Regions (2015-2026)
4.2 Global Long-acting Injectable Medications Sales Analysis and Forecast by Regions (2015-2026)
4.3 Global Long-acting Injectable Medications Sales Revenue Analysis and Forecast by Regions (2015-2026)

Chapter Five: Value Chain (Impact of COVID-19)
5.1 Long-acting Injectable Medications Value Chain Analysis
5.1.1 Upstream
5.1.2 Downstream
5.2 COVID-19 Impact on Long-acting Injectable Medications Industry
5.2.1 Industrial Policy Issued Under the Epidemic Situation
5.3 Cost-Under the Epidemic Situation
5.3.1 Cost of Raw Material
5.4 Channel Analysis
5.4.1 Distribution Channel-Under the Epidemic Situation
5.4.2 Distributors

Chapter Six: Competitive Landscape
6.1 Global Long-acting Injectable Medications Capacity Market Share of Manufacturers (2019-2020)
6.2 Global Long-acting Injectable Medications Sales Market Share of Manufacturers (2019-2020)
6.3 Global Long-acting Injectable Medications Sales Revenue Market Share of Manufacturers (2019-2020)

Chapter Seven: Long-acting Injectable Medications Competitive Analysis
7.1 Eli Lilly
7.1.1 Eli Lilly Company Profiles
7.1.2 Eli Lilly Product Introduction
7.1.3 Eli Lilly Long-acting Injectable Medications Production, Revenue (2015-2020)
7.1.4 SWOT Analysis
7.2 Nanomi
7.2.1 Nanomi Company Profiles
7.2.2 Nanomi Product Introduction
7.2.3 Nanomi Long-acting Injectable Medications Production, Revenue (2015-2020)
7.2.4 SWOT Analysis
7.3 Alkermes
7.3.1 Alkermes Company Profiles
7.3.2 Alkermes Product Introduction
7.3.3 Alkermes Long-acting Injectable Medications Production, Revenue (2015-2020)
7.3.4 SWOT Analysis
7.4 Zogenix
7.4.1 Zogenix Company Profiles
7.4.2 Zogenix Product Introduction
7.4.3 Zogenix Long-acting Injectable Medications Production, Revenue (2015-2020)
7.4.4 SWOT Analysis
7.5 DURECT
7.5.1 DURECT Company Profiles
7.5.2 DURECT Product Introduction
7.5.3 DURECT Long-acting Injectable Medications Production, Revenue (2015-2020)
7.5.4 SWOT Analysis
7.6 Johnson & Johnson
7.6.1 Johnson & Johnson Company Profiles
7.6.2 Johnson & Johnson Product Introduction
7.6.3 Johnson & Johnson Long-acting Injectable Medications Production, Revenue (2015-2020)
7.6.4 SWOT Analysis
7.7 MedinCell
7.7.1 MedinCell Company Profiles
7.7.2 MedinCell Product Introduction
7.7.3 MedinCell Long-acting Injectable Medications Production, Revenue (2015-2020)
7.7.4 SWOT Analysis
7.8 Mapi Pharma
7.8.1 Mapi Pharma Company Profiles
7.8.2 Mapi Pharma Product Introduction
7.8.3 Mapi Pharma Long-acting Injectable Medications Production, Revenue (2015-2020)
7.8.4 SWOT Analysis
7.9 Oakwood Labs
7.9.1 Oakwood Labs Company Profiles
7.9.2 Oakwood Labs Product Introduction
7.9.3 Oakwood Labs Long-acting Injectable Medications Production, Revenue (2015-2020)
7.9.4 SWOT Analysis
7.10 GSK
7.10.1 GSK Company Profiles
7.10.2 GSK Product Introduction
7.10.3 GSK Long-acting Injectable Medications Production, Revenue (2015-2020)
7.10.4 SWOT Analysis
7.11 Pharmathen
7.12 Kashiv BioSciences

Chapter Eight: Conclusion

List of Tables and Figures
Figure Product Introduction
Table Production (K Units) and Revenue (Million USD) of Major Players (2015-2020)
Figure Global Long-acting Injectable Medications Production Market Share of Top 5 Players
Table CAGR of Major Market (2021-2026)
Table CAGR in Terms of Production of Each Type (2015-2026)
Table CAGR in Terms of Production of Each Application (2015-2026)
Table Global Long-acting Injectable Medications Sales (K Unit) by Type (2015-2026)
Figure Global Long-acting Injectable Medications Sales (K Unit) and Growth Rate (2015-2026)
Figure Global Long-acting Injectable Medications Sales Market Share (%) by Type (2019 -2020)
Table Global Long-acting Injectable Medications Sales Value (Million USD) by Type (2015-2026)
Figure Global Long-acting Injectable Medications Sales Value (Million USD) and Growth Rate (2015-2026)
Figure Global Long-acting Injectable Medications Sales Value Market Share (%) by Type (2019-2020)
Table Global Long-acting Injectable Medications Sales (K Unit) by Application (2015-2026)
Figure China Long-acting Injectable Medications Production Value (Million USD) and Growth Rate (2015-2026)
Table China Long-acting Injectable Medications Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure EU Long-acting Injectable Medications Production Value (Million USD) and Growth Rate (2015-2026)
Table EU Long-acting Injectable Medications Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure North America Long-acting Injectable Medications Production Value (Million USD) and Growth Rate (2015-2026)
Table North America Long-acting Injectable Medications Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure Japan Long-acting Injectable Medications Production Value (Million USD) and Growth Rate (2015-2026)
Table Japan Long-acting Injectable Medications Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure India Long-acting Injectable Medications Production Value (Million USD) and Growth Rate (2015-2026)
Table India Long-acting Injectable Medications Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure Southeast Asia Long-acting Injectable Medications Production Value (Million USD) and Growth Rate (2015-2026)
Table Southeast Asia Long-acting Injectable Medications Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure South America Long-acting Injectable Medications Production Value (Million USD) and Growth Rate (2015-2026)
Table South America Long-acting Injectable Medications Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure Middle East and Africa Long-acting Injectable Medications Production Value (Million USD) and Growth Rate (2015-2026)
Table Middle East and Africa Long-acting Injectable Medications Local Capacity, Import, Export and Local Consumption (2015-2020)
Table Global Long-acting Injectable Medications Capacity (K Units) and Growth Rate (2015-2026)
Figure Global Long-acting Injectable Medications Capacity (K Units) and Growth Rate (2015-2026)
Table Global Long-acting Injectable Medications Sales (Unit) by Type (2015-2026)
Figure Global Long-acting Injectable Medications Sales(Unit) and Growth Rate (2015-2026)
Table Sales Market Share (%) by Type (2019-2026)
Table Global Long-acting Injectable Medications Sales Revenue (Million USD) by Type (2015-2026)
Figure Global Long-acting Injectable Medications Sales Revenue (Million USD) and Growth Rate (2015-2026)
Table Sales Revenue Market Share (%) by Type (2019-2026)
Table Global Long-acting Injectable Medications Consumption (Unit) by Application (2015-2026)
Figure Global Long-acting Injectable Medications Consumption (Unit) and Growth Rate (2015-2026)
Table Consumption Market Share (%) by Application (2019-2026)
Table Global Long-acting Injectable Medications Production (K Unite) by Regions (2015-2020)
Table Global Long-acting Injectable Medications CAGR (%) in term of Production and Market Share by Regions (2015-2026)
Figure Global Long-acting Injectable Medications Production Share by Regions (2019-2020)
Table Global Long-acting Injectable Medications Sales (K Unite) by Regions (2015-2020)
Table Global Long-acting Injectable Medications CAGR (%) in term of Sales and Market Share by Regions (2015-2026)
Figure Global Long-acting Injectable Medications Sales Share by Regions (2019-2020)
Table Global Long-acting Injectable Medications Sales Revenue (Million USD) by Regions (2015-2020)
Table Global Long-acting Injectable Medications CAGR (%) in term of Sales Revenue and Market Share by Regions (2015-2026)
Figure Global Long-acting Injectable Medications Sales Revenue Share by Regions (2019-2020)
Figure Value Chain Structure of Long-acting Injectable Medications
Table Value Chain
Table Key Suppliers of Raw Material/Components
Table Key Downstream Customer in Each Application Field
Table Industry News List of Long-acting Injectable Medications
Figure Cost Structure of Long-acting Injectable Medications in 2020
Table Global Long-acting Injectable Medications Capacity Share of Manufacturers (2019-2020)
Figure Global Long-acting Injectable Medications Capacity Share of Manufacturers (2019-2020)
Table Global Long-acting Injectable Medications Sales Market Share of Manufacturers (2019-2020)
Figure Global Long-acting Injectable Medications Sales Market Share of Manufacturers (2019-2020)
Table Global Long-acting Injectable Medications Sales Revenue Market Share of Manufacturers (2019-2020)
Figure Global Long-acting Injectable Medications Sales Revenue Market Share of Manufacturers (2019-2020)
Figure Global Long-acting Injectable Medications Sales Value (Million USD), Growth Rate & Market Share (2021-2026)
Table Eli Lilly Profiles
Table Eli Lilly Long-acting Injectable Medications Product Introduction
Table Eli Lilly Long-acting Injectable Medications Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure Eli Lilly SWOT Analysis
Table Nanomi Profiles
Table Nanomi Long-acting Injectable Medications Product Introduction
Table Nanomi Long-acting Injectable Medications Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure Nanomi SWOT Analysis
Table Alkermes Profiles
Table Alkermes Long-acting Injectable Medications Product Introduction
Table Alkermes Long-acting Injectable Medications Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure Alkermes SWOT Analysis
Table Zogenix Profiles
Table Zogenix Long-acting Injectable Medications Product Introduction
Table Zogenix Long-acting Injectable Medications Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure Zogenix SWOT Analysis
Table DURECT Profiles
Table DURECT Long-acting Injectable Medications Product Introduction
Table DURECT Long-acting Injectable Medications Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure DURECT SWOT Analysis
Table Johnson & Johnson Profiles
Table Johnson & Johnson Long-acting Injectable Medications Product Introduction
Table Johnson & Johnson Long-acting Injectable Medications Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure Johnson & Johnson SWOT Analysis
Table MedinCell Profiles
Table MedinCell Long-acting Injectable Medications Product Introduction
Table MedinCell Long-acting Injectable Medications Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure MedinCell SWOT Analysis
Table Mapi Pharma Profiles
Table Mapi Pharma Long-acting Injectable Medications Product Introduction
Table Mapi Pharma Long-acting Injectable Medications Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure Mapi Pharma SWOT Analysis
Table Oakwood Labs Profiles
Table Oakwood Labs Long-acting Injectable Medications Product Introduction
Table Oakwood Labs Long-acting Injectable Medications Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure Oakwood Labs SWOT Analysis
Table GSK Profiles
Table GSK Long-acting Injectable Medications Product Introduction
Table GSK Long-acting Injectable Medications Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure GSK SWOT Analysis
Table Pharmathen Profiles
Table Pharmathen Long-acting Injectable Medications Product Introduction
Table Pharmathen Long-acting Injectable Medications Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure Pharmathen SWOT Analysis
Table Kashiv BioSciences Profiles
Table Kashiv BioSciences Long-acting Injectable Medications Product Introduction
Table Kashiv BioSciences Long-acting Injectable Medications Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure Kashiv BioSciences SWOT Analysis